Study: Aflibercept Superior to Ranibizumab in Inflammation Control after Vitrectomy
Although both anti-VEGFs maintain a consistent safety profile, aflibercept shows a more pronounced short-term inhibitory effect on inflammation after vitrectomy for diabetic retinopathy.
Source: hcplive.com